Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LJPC-401
LJPC-401
La Jolla shares fall on CEO departure, clinical trial results
Marketwatch
Mon, 11/25/19 - 10:00 am
La Jolla Pharmaceutical
George Tidmarsh
LJPC-401